Excretion of methadone in sweat of pregnant women throughout gestation after controlled methadone administration

Therapeutic Drug Monitoring

Volumn 32, Issue 4, 2010, Pages 497-503

  Barnes, Allan J ^a   Brunet, Bertrand R ^b   Choo, Robin E ^c   Mura, Patrick ^d   Johnson, Rolley E ^e,f   Jones, Hendrée E ^e   Huestis, Marilyn A ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b UNIVERSITÉ DE POITIERS   (France)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d POITIERS UNIVERSITY HOSPITAL   (France)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f RECKITT BENCKISER   (United Kingdom)

Author keywords

alternative matrix; drug testing; methadone; sweat; therapeutic drug monitoring

Indexed keywords

ACETIC ACID; METHADONE; NARCOTIC ANALGESIC AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; DOSE RESPONSE; DRUG EXCRETION; FEMALE; HUMAN; INFORMED CONSENT; OPIATE ADDICTION; OUTPATIENT CARE; PREGNANCY; PREGNANT WOMAN; PRIORITY JOURNAL; SWEAT TEST; COST BENEFIT ANALYSIS; DRUG MONITORING; LABORATORY DIAGNOSIS; MASS FRAGMENTOGRAPHY; METABOLISM; OPIOID-RELATED DISORDERS; REPRODUCIBILITY; SWEAT; YOUNG ADULT;

ADULT; ANALGESICS, OPIOID; COST-BENEFIT ANALYSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG MONITORING; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; METHADONE; OPIOID-RELATED DISORDERS; PREGNANCY; REPRODUCIBILITY OF RESULTS; SPECIMEN HANDLING; SWEAT; YOUNG ADULT;

EID: 77955176062     PISSN: 01634356     EISSN: 15363694     Source Type: Journal    
DOI: 10.1097/FTD.0b013e3181e44293     Document Type: Article

References (32)

1. Blinick G, Wallach RC, Jerez E. Pregnancy in narcotics addicts treated by medical withdrawal. Am J Obstet Gynecol. 1969;105:997-1003.
2. Blinick G, Wallach RC, Jerez E, et al. Drug addiction in pregnancy and the neonate. Am J Obstet Gynecol. 1976;125:135-142.
3. Finnegan LP. Perinatal substance abuse: comments and perspectives. Semin Perinatol. 1991;15:331-339.
4. Naeye RL, Blanc W, Leblanc W, et al. Fetal complications of maternal heroin addiction: abnormal growth, infections, and episodes of stress. J Pediatr. 1973;83:1055-1061.
5. Jones HE, O'Grady KE, Malfi D, et al. Methadone maintenance vs. methadone taper during pregnancy: maternal and neonatal outcomes. Am J Addict. 2008;17:372-386.
6. Kintz P. Drug testing in addicts: a comparison between urine, sweat, and hair. Ther Drug Monit. 1996;18:450-455.
7. Bosker WM, Huestis MA. Oral fluid testing for drugs of abuse. Clin Chem. 2009;55:1910-1931.
8. Choo RE, Huestis MA. Oral fluid as a diagnostic tool. Clin Chem Lab Med. 2004;42:1273-1287
9. DHHS. Proposed revisions to mandatory guidelines for federal workplace drug testing programs. Fed Regist. 2004;69:19673-19732.
10. Cone EJ, Hillsgrove MJ, Jenkins AJ, et al. Sweat testing for heroin, cocaine, and metabolites. J Anal Toxicol. 1994;18:298-305.
11. Henderson GL, Wilson BK. Excretion of methadone and metabolites in human sweat. Res Commun Chem Pathol Pharmacol. 1973;5:1-8.
12. Skopp G, Potsch L, Eser HP, et al. Preliminary practical findings on drug monitoring by a transcutaneous collection device. J Forensic Sci. 1996;41: 933-937.
13. Fucci N, De Giovanni N, Scarlata S. Sweat testing in addicts under methadone treatment: an Italian experience. Forensic Sci Int. 2008;174: 107-110.
14. Kintz P, Tracqui A, Marzullo C, et al. Enantioselective analysis of methadone in sweat as monitored by liquid chromatography/ion spray-mass spectrometry. Ther Drug Monit. 1998;20:35-40.
15. Brunet BR, Barnes AJ, Scheidweiler KB, et al. Development and validation of a solid-phase extraction gas chromatography-mass spectrometry method for the simultaneous quantification of methadone, heroin, cocaine and metabolites in sweat. Anal Bioanal Chem. 2008;392: 115-127.
16. Krouwer JS, Rabinowitz R. How to improve estimates of imprecision. Clin Chem. 1984;30:290-292.
17. Huestis MA, Cone EJ, Wong CJ, et al. Monitoring opiate use in substance abuse treatment patients with sweat and urine drug testing. J Anal Toxicol. 2000;24:509-521.
18. Preston KL, Huestis MA, Wong CJ, et al. Monitoring cocaine use in substance abuse treatment patients by sweat and urine testing. J Anal Toxicol. 1999;23:313-322.
19. Schwilke EW, Barnes AJ, Kacinko SL, et al. Opioid disposition in human sweat after controlled oral codeine administration. Clin Chem. 2006;52: 1539-1545.
20. Kacinko SL, Barnes AJ, Schwilke EW, et al. Disposition of cocaine and its metabolites in human sweat after controlled cocaine administration. Clin Chem. 2005;51:2085-2094.
21. Barnes AJ, Smith ML, Kacinko SL, et al. Excretion of methamphetamine and amphetamine in human sweat following controlled oral metham-phetamine administration. Clin Chem. 2008;54:172-180.
22. Kintz P, Cirimele V, Ludes B. Codeine testing in sweat and saliva with the Drugwipe. Int J Leg Med. 1998;111:82-84.
23. Kintz P, Tracqui A, Mangin P, et al. Sweat testing in opioid users with a sweat patch. J Anal Toxicol. 1996;20:393-397.
24. De Martinis BS, Barnes AJ, Scheidweiler KB, et al. Development and validation of a disk solid phase extraction and gas chromatography-mass spectrometry method for MDMA, MDA, HMMA, HMA, MDEA, methamphetamine and amphetamine in sweat. J Chromatogr B Analyt Technol Biomed Life Sci. 2007;852:450-458.
25. Saito T, Wtsadik A, Scheidweiler KB, et al. Validated gas chromato-graphic-negative ion chemical ionization mass spectrometric method for delta(9)-tetrahydrocannabinol in sweat patches. Clin Chem. 2004;50: 2083-2090.
26. Brunet BR, Barnes AJ, Choo RE, et al. Monitoring pregnant women's illicit opiate and cocaine use with sweat testing. Ther Drug Monit. 2010; 32:40-49.
27. Muallem M, Rubeiz N. Physiological and biological skin changes in pregnancy. Clin Dermatol. 2006;24:80-83.
28. Al-Adwani A, Basu N. Methadone and excessive sweating. Addiction. 2004;99:259-259
29. Appenzeller BM, Schummer C, Rodrigues SB, et al. Determination of the volume of sweat accumulated in a sweat-patch using sodium and potassium as internal reference. J Chromatogr B Analyt Technol Biomed Life Sci. 2007;852:333-337.
30. Schummer C, Appenzeller BMR, Wennig R. Quantitative determination of ethyl glucuronide in sweat. Ther Drug Monit. 2008;30:536-539.
31. Barnes AJ, De Martinis BS, Gorelick DA, et al. Disposition of MDMA and metabolites in human sweat following controlled MDMA administration. Clin Chem. 2009;55:454-462.
32. Uemura N, Nath RP, Harkey MR, et al. Cocaine levels in sweat collection patches vary by location of patch placement and decline over time. J Anal Toxicol. 2004;28:253-259.